TSS
DNA icon

Two Sigma Securities’s Ginkgo Bioworks DNA Stock Holding History

Two Sigma Securities’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,853
Closed -$51.5K – 3092
2024
Q2 		$51.5K Buy
3,853
+301
+8% +$8.98K ﹤0.01% 2570
2024
Q1 		$165K Buy
+3,552
New +$184K 0.01% 2386
2023
Q3 		– Sell
-1,002
Closed -$74.5K – 3111
2023
Q2 		$74.5K Sell
1,002
-1,551
-61% -$91.8K 0.01% 2346
2023
Q1 		$136K Buy
2,553
+191
+8% +$12.1K 0.01% 2158
2022
Q4 		$160K Buy
2,362
+2,066
+698% +$190K 0.02% 1996
2022
Q3 		$37K Buy
+296
New +$35.3K 0.01% 2221

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return